Skip to main content

Table 2 Mean changes from baseline in components of the bishop score at 24 h

From: Recombinant human relaxin versus placebo for cervical ripening: a double-blind randomised trial in pregnant women scheduled for induction of labour

  Mean ± SD
Pooled MTDa
n = 26
Pooled Placeboa
n = 23
Cervical Dilatation (cm) 0.63 ± 0.81 1.35 ± 1.21
Effacement (%) 0.43 ± 0.59 0.65 ± 0.75
Station 0.50 ± 1.45 0.44 ± 0.71
Consistency 0.83 ± 0.78 0.92 ± 0.63
Position of Cervix 0.83 ± 0.83 1.19 ± 0.69
  1. Mean changes from baseline in the individual components of the Bishop score at 24 h were calculated post-hoc in all patients receiving 24 h of study drug with Bishop scores available at baseline and 24 h
  2. aPooled Maximum Tolerated Dose (MTD) group includes subjects who were administered the 75 μg/kg/day dose in Parts A and B of the study. Pooled placebo group includes subjects who received placebo in Parts A and B